Feb. 16, 2026
Neuroendocrine Tumors Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment
DelveInsight's analysis of the Neuroendocrine Tumors pipeline reveals 70+ key companies working on 75+ therapies
Feb. 13, 2026
Experimental drug doubles survival of ovarian cancer patients in trial
Elenagen combined with standard chemotherapy shows dramatic improvement in median survival for women with ovarian cancer resistant to first-line treatments.
Feb. 12, 2026
Glioblastoma Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals
DelveInsight's analysis of the Glioblastoma pipeline reveals over 200 key companies working on 220+ treatment therapies
Feb. 12, 2026
Sponsorship Opportunities Open for Advances in Endoscopic Oncology 2026
Key conference to showcase cutting-edge GI cancer treatments in Las Vegas
Feb. 9, 2026
Las Vegas Breast Cancer Survivor Receives 'Horrifying' Letter About Faulty Mammograms
Summerlin Hospital ordered to stop performing mammography after failing to meet FDA standards
Feb. 9, 2026
Teddi Mellencamp Reflects on 1-Year Anniversary of Stage 4 Cancer Diagnosis
The reality star revealed she thought she had 'migraines' at the time of her diagnosis.
